neisvac-c vaccine meningococcal group c polysaccharide conjugate vaccine suspension for injection syringe
pfizer australia pty ltd - tetanus toxoid, quantity: 20 microgram/ml; meningococcal polysaccharide group c, quantity: 20 microgram/ml - injection, suspension - excipient ingredients: sodium chloride; water for injections; aluminium hydroxide hydrate - neisvac-c vaccine is indicated for active immunisation of children from 8 weeks of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis serogroup c.
pneumococcal polysaccharide conjugate vaccine(adsorbed) (10 valent) 5 dose suspension for injection
serum institute of india pvt. ltd. (siipl), india - monovalent bulk conjugates (saccharides for each serotypes 1, 5, 6a, 6b, 9v, 7f, 14, 19a, 19f, 23f conjugated to crm197carrier protein) - suspension for injection - 2+4 mcg/0.5ml
pneumococcal polysaccharide conjugate vaccine(adsorbeb) (10 valent) 1 dose suspension for injection
serum institute of india pvt. ltd. (siipl), india - monovalent bulk conjugates (saccharides for each serotypes 1, 5, 6a, 6b, 9v, 7f, 14, 19a, 19f, 23f conjugated to crm197carrier protein) - suspension for injection - 2+4 mcg/0.5ml
pneumovax 23 solution for injection in pre-filled syringe / pneumococcal polysaccharide vaccine
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pneumococcal polysaccharide, serotype, conjugated to, crm, b conjugated, to crm, f conjugated, n conjugated, v conjugated, a conjugated, c conjugated - solution for injection in a pre-filled syringe - pneumococcal polysaccharide serotype 1 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 2 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 3 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 4 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 5 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 6b conjugated to crm197 25 µg pneumococcal polysaccharide serotype 7f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 8 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 9n conjugated to crm197 25 µg pneumococcal polysaccharide serotype 9v conjugated to crm197 25 µg pneumococcal polysaccharide serotype 10a conjugated to crm197 25 µg pneumococcal polysaccharide serotype 11a conjugated to crm197 25 µg pneumococcal polysaccharide serotype 12f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 14 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 15b conjugated to crm197 25 µg pneumococcal polysaccharide serotype 17f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 18c conjugated to crm197 25 µg pneumococcal polysaccharide serotype 19a conjugated to crm197 25 µg pneumococcal polysaccharide serotype 19f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 20 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 22f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 23f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 33f conjugated to crm197 25 µg - vaccines
pneumococcal polysaccharide conjugate vaccine(adsorbeb) (10 valent) suspension for injection 2+4 mcg/0.5ml
serum institute of india private limited , india - pneumococcal polysaccharide serotype - suspension for injection - 2+4 mcg/0.5ml
pneumococcal polysaccharide conjugate vaccine(adsorbeb) (10 valent) 1 dose suspension for injection 2+4 mcg/0.5ml
serum institute of india private limited , india - pneumococcal polysaccharide serotype - suspension for injection - 2+4 mcg/0.5ml
pneumovax 23, solution for injection in pre-filled syringe pneumococcal polysaccharide vaccine
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pneumococcal polysaccharide, serotype, conjugated to, crm, b conjugated, to crm, f conjugated, n conjugated, v conjugated, a conjugated, c conjugated - solution for injection in a pre-filled syringe - pneumococcal polysaccharide serotype 1 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 2 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 3 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 4 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 5 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 6b conjugated to crm197 25 µg pneumococcal polysaccharide serotype 7f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 8 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 9n conjugated to crm197 25 µg pneumococcal polysaccharide serotype 9v conjugated to crm197 25 µg pneumococcal polysaccharide serotype 10a conjugated to crm197 25 µg pneumococcal polysaccharide serotype 11a conjugated to crm197 25 µg pneumococcal polysaccharide serotype 12f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 14 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 15b conjugated to crm197 25 µg pneumococcal polysaccharide serotype 17f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 18c conjugated to crm197 25 µg pneumococcal polysaccharide serotype 19f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 19a conjugated to crm197 25 µg pneumococcal polysaccharide serotype 20 conjugated to crm197 25 µg pneumococcal polysaccharide serotype 22f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 23f conjugated to crm197 25 µg pneumococcal polysaccharide serotype 33f conjugated to crm197 25 µg - vaccines
vaxneuvance pneumococcal 15-valent conjugate vaccine [crm197 protein], adsorbed 0.5 ml suspension for intramuscular injection, pre-filled syringe
merck sharp & dohme (australia) pty ltd - pneumococcal purified capsular polysaccharides, quantity: 2 microgram; pneumococcal purified capsular polysaccharides, quantity: 4 microgram - injection, suspension - excipient ingredients: polysorbate 20; histidine; sodium chloride; aluminium; water for injections; diphtheria crm197 protein - vaxneuvance is indicated for active immunisation for the prevention of pneumococcal disease caused by streptococcus pneumoniae serotypes (1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f, 22f, 23f and 33f) in adults and children from 6 weeks of age. vaxneuvance may not prevent disease caused by s. pneumoniae serotypes that are not contained in the vaccine. the use of vaxneuvance should be guided by official recommendations.
pneumovax 23
msd pharma (singapore) pte. ltd. - pneumococcal polysaccharides 23 most prevalent types - injection - 25mcg/0.5ml each - pneumococcal polysaccharides 23 most prevalent types 25mcg/0.5ml each
prevenar
pfizer new zealand limited - pneumococcal polysaccharide serotype 14 2ug (conjugated with diphtheria crm 197 protein); pneumococcal polysaccharide serotype 18c 2ug (conjugated with diphtheria crm 197 protein); pneumococcal polysaccharide serotype 19f 2ug (conjugated with diphtheria crm 197 protein); pneumococcal polysaccharide serotype 23f 2ug (conjugated with diphtheria crm 197 protein); pneumococcal polysaccharide serotype 4 2ug (conjugated with diphtheria crm 197 protein); pneumococcal polysaccharide serotype 6b 4ug (conjugated with diphtheria crm 197 protein); pneumococcal polysaccharide serotype 9v 2ug (conjugated with diphtheria crm 197 protein) - suspension for injection - 0.5 ml - active: pneumococcal polysaccharide serotype 14 2ug (conjugated with diphtheria crm 197 protein) pneumococcal polysaccharide serotype 18c 2ug (conjugated with diphtheria crm 197 protein) pneumococcal polysaccharide serotype 19f 2ug (conjugated with diphtheria crm 197 protein) pneumococcal polysaccharide serotype 23f 2ug (conjugated with diphtheria crm 197 protein) pneumococcal polysaccharide serotype 4 2ug (conjugated with diphtheria crm 197 protein) pneumococcal polysaccharide serotype 6b 4ug (conjugated with diphtheria crm 197 protein) pneumococcal polysaccharide serotype 9v 2ug (conjugated with diphtheria crm 197 protein) excipient: aluminium phosphate sodium chloride water for injection